Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202067994> ?p ?o ?g. }
- W3202067994 endingPage "121140" @default.
- W3202067994 startingPage "121140" @default.
- W3202067994 abstract "The in vivo fate of nanoformulated drugs is governed by the physicochemical properties of the drug and the functionality of nanocarriers. Nanoformulations such as polymeric micelles, which physically encapsulate poorly soluble drugs, release their payload into the bloodstream during systemic circulation. This results in three distinct fractions of the drug-nanomedicine: encapsulated, protein-bound, and free drug. Having a thorough understanding of the pharmacokinetic (PK) profiles of each fraction is essential to elucidate mechanisms of nanomedicine-driven changes in drug exposure and PK/PD relationships pharmacodynamic activity. Here, we present a comprehensive preclinical assessment of the poly (2-oxazoline)-based polymeric micelle of paclitaxel (PTX) (POXOL hl-PM), including bioequivalence comparison to the clinically approved paclitaxel nanomedicine, Abraxane®. Physicochemical characterization and toxicity analysis of POXOL hl-PM was conducted using standardized protocols by the Nanotechnology Characterization Laboratory (NCL). The bioequivalence of POXOL hl-PM to Abraxane® was evaluated in rats and rhesus macaques using the NCL's established stable isotope tracer ultrafiltration assay (SITUA) to delineate the plasma PK of each PTX fraction. The SITUA study revealed that POXOL hl-PM and Abraxane® had comparable PK profiles not only for total PTX but also for the distinct drug fractions, suggesting bioequivalence in given animal models. The comprehensive preclinical evaluation of POXOL hl-PM in this study showcases a series of widely applicable standardized studies by NCL for assessing nanoformulations prior to clinical investigation." @default.
- W3202067994 created "2021-10-11" @default.
- W3202067994 creator A5004559356 @default.
- W3202067994 creator A5010824862 @default.
- W3202067994 creator A5017026309 @default.
- W3202067994 creator A5029598800 @default.
- W3202067994 creator A5030392197 @default.
- W3202067994 creator A5031954491 @default.
- W3202067994 creator A5036799572 @default.
- W3202067994 creator A5036925342 @default.
- W3202067994 creator A5055208021 @default.
- W3202067994 creator A5056405812 @default.
- W3202067994 creator A5062608685 @default.
- W3202067994 creator A5070297217 @default.
- W3202067994 creator A5071548869 @default.
- W3202067994 creator A5090225444 @default.
- W3202067994 date "2021-11-01" @default.
- W3202067994 modified "2023-10-14" @default.
- W3202067994 title "Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay" @default.
- W3202067994 cites W105680442 @default.
- W3202067994 cites W1587071366 @default.
- W3202067994 cites W1836451026 @default.
- W3202067994 cites W1946235557 @default.
- W3202067994 cites W1963410277 @default.
- W3202067994 cites W1974290383 @default.
- W3202067994 cites W1987259801 @default.
- W3202067994 cites W1991525295 @default.
- W3202067994 cites W1994070029 @default.
- W3202067994 cites W1996217277 @default.
- W3202067994 cites W2001983171 @default.
- W3202067994 cites W2005452896 @default.
- W3202067994 cites W2017976511 @default.
- W3202067994 cites W2055353351 @default.
- W3202067994 cites W2061239263 @default.
- W3202067994 cites W2064391774 @default.
- W3202067994 cites W2065735911 @default.
- W3202067994 cites W2076670186 @default.
- W3202067994 cites W2078502975 @default.
- W3202067994 cites W2080774121 @default.
- W3202067994 cites W2097688080 @default.
- W3202067994 cites W2101935997 @default.
- W3202067994 cites W2114095008 @default.
- W3202067994 cites W2142161221 @default.
- W3202067994 cites W2153017356 @default.
- W3202067994 cites W2184694295 @default.
- W3202067994 cites W2347029037 @default.
- W3202067994 cites W2409885204 @default.
- W3202067994 cites W2524334680 @default.
- W3202067994 cites W2554667159 @default.
- W3202067994 cites W2576084499 @default.
- W3202067994 cites W2765373345 @default.
- W3202067994 cites W2807377921 @default.
- W3202067994 cites W2811501377 @default.
- W3202067994 cites W2899192398 @default.
- W3202067994 cites W2948091418 @default.
- W3202067994 cites W3010491497 @default.
- W3202067994 cites W3012542984 @default.
- W3202067994 cites W3021349866 @default.
- W3202067994 cites W3036026766 @default.
- W3202067994 cites W3088981963 @default.
- W3202067994 cites W3107716592 @default.
- W3202067994 cites W3136876570 @default.
- W3202067994 cites W606839851 @default.
- W3202067994 doi "https://doi.org/10.1016/j.biomaterials.2021.121140" @default.
- W3202067994 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34634661" @default.
- W3202067994 hasPublicationYear "2021" @default.
- W3202067994 type Work @default.
- W3202067994 sameAs 3202067994 @default.
- W3202067994 citedByCount "14" @default.
- W3202067994 countsByYear W32020679942022 @default.
- W3202067994 countsByYear W32020679942023 @default.
- W3202067994 crossrefType "journal-article" @default.
- W3202067994 hasAuthorship W3202067994A5004559356 @default.
- W3202067994 hasAuthorship W3202067994A5010824862 @default.
- W3202067994 hasAuthorship W3202067994A5017026309 @default.
- W3202067994 hasAuthorship W3202067994A5029598800 @default.
- W3202067994 hasAuthorship W3202067994A5030392197 @default.
- W3202067994 hasAuthorship W3202067994A5031954491 @default.
- W3202067994 hasAuthorship W3202067994A5036799572 @default.
- W3202067994 hasAuthorship W3202067994A5036925342 @default.
- W3202067994 hasAuthorship W3202067994A5055208021 @default.
- W3202067994 hasAuthorship W3202067994A5056405812 @default.
- W3202067994 hasAuthorship W3202067994A5062608685 @default.
- W3202067994 hasAuthorship W3202067994A5070297217 @default.
- W3202067994 hasAuthorship W3202067994A5071548869 @default.
- W3202067994 hasAuthorship W3202067994A5090225444 @default.
- W3202067994 hasBestOaLocation W32020679942 @default.
- W3202067994 hasConcept C111113717 @default.
- W3202067994 hasConcept C112705442 @default.
- W3202067994 hasConcept C121608353 @default.
- W3202067994 hasConcept C126322002 @default.
- W3202067994 hasConcept C15083742 @default.
- W3202067994 hasConcept C155672457 @default.
- W3202067994 hasConcept C171250308 @default.
- W3202067994 hasConcept C18150654 @default.
- W3202067994 hasConcept C185592680 @default.
- W3202067994 hasConcept C185867374 @default.
- W3202067994 hasConcept C192562407 @default.